Lundbeck sues generics firms: ”The time and money would have been better spent in the laboratory”
Lundbeck has sued five companies aiming to develop generic versions of the drug group’s bestselling antidepressant Trintellix. Lundbeck representative says the Danish company could do without the court cases but is forced to take legal action.
BY MARTIN HAVTORN PETERSEN
Danish drug group Lundbeck has set its US lawyers working after launching a patent infringement lawsuit against five generics companies. However, the company denies having initiated the legal disputes and says it would prefer to be spared the trouble.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Lundbeck and Teva settle compensation case for millions
For abonnenter
Lundbeck executive: I knew FDA had another opinion
For abonnenter
